Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization

Colloids and Surfaces B: Biointerfaces

Volumn 82, Issue 1, 2011, Pages 118-125

  Gupta, Prem N ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

HBsAg; Liposomes; M cells; Ulex europaeus 1; Vaccine delivery

Indexed keywords

BALB/C MICE; BIOLOGICAL MODELS; CYTOKINES; ENCAPSULATION EFFICIENCY; HBSAG; HEPATITIS B SURFACE ANTIGEN; IN-VITRO; INTERLEUKIN-2; M-CELLS; MUCOSAL IMMUNIZATION; MUCOSAL SECRETIONS; MUCOSAL VACCINE; PEYER'S PATCHES; STAINING TECHNIQUES; SURFACE-MODIFIED; ULEX EUROPAEUS 1; VACCINE DELIVERY;

BODY FLUIDS; ENCAPSULATION; IMMUNIZATION; PHOSPHOLIPIDS; POLYDISPERSITY; VACCINES;

LIPOSOMES;

ALUMINUM POTASSIUM SULFATE; DRUG CARRIER; FUCOSE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLIPOSOME; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; ULEX EUROPAEUS AGGLUTININ; ULEX EUROPAEUS AGGLUTININ 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG CONJUGATION; DRUG FORMULATION; DRUG TARGETING; DRUG UPTAKE; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; INTESTINE SECRETION; LIPOSOMAL DELIVERY; MOUSE; MUCOSA CELL; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPLEEN; STAINING; SURFACE PROPERTY; TARGET CELL; TISSUE HOMOGENATE; TISSUE LEVEL; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; DRUG CARRIERS; FEMALE; HEPATITIS B SURFACE ANTIGENS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; LIGANDS; LIPOSOMES; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; PARTICLE SIZE; PEYER'S PATCHES; PLANT LECTINS; SPLEEN;

BOVINAE; MUS; ULEX EUROPAEUS;

EID: 77957671451     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.08.027     Document Type: Article

References (46)

1. Jaganathan K.S., Vyas S.P. Vaccine 2006, 24:4201.
2. Davis S.S. Adv. Drug Deliv. Rev. 2001, 51:21.
3. Levine M.M. Nat. Med. 2003, 9:99.
4. Clark M.A., Blair H., Liang L., Brey R.N., Brayden D., Hirst B.H. Vaccine 2001, 20:208.
5. Magistris M.T.D. Adv. Drug Deliv. Rev. 2006, 58:52.
6. Myschik J., Rades T., Hook S. Curr. Immunol. Rev. 2009, 5:42.
7. Lyu S.Y., Park W.B. Arch. Pharm. Res. 2008, 31:1613.
8. Lavelle E.C., Grant G., Pusztai A., Fuller U., O'Hagan D.T. Immunology 2001, 102:77.
9. Gupta P.N., Khatri K., Goyal A.K., Mishra N., Vyas S.P. J. Drug Target 2007, 15:701.
10. Brayden D., Jepson M.A., Baird A.W. Drug Discov. Today 2005, 10:1145.
11. Wilding I.R., Davis S.S., O'Hagan D.T. Pharmacol. Ther. 1994, 62:97.
12. Clark M.A., Hirst B.H., Jepson M.A. Adv. Drug Deliv. Rev. 2000, 43:207.
13. Frey A., Neutra M.R. Behring Inst. Mitt. 1997, 98:376.
14. Holmgren J., Czerkinsky C. Nat. Med. 2005, 11:S45.
15. Katz D.E., Delorimier A.J., Wolf M.K., Hall E.R., Cassels F.J., van Hamont J.E., Newcomer R.L., Davachi M.A., Taylor D.N., Charles E., McQueen C.E. Vaccine 2003, 21:341.
16. Vyas S.P., Gupta P.N. Expert Rev. Vaccines 2007, 6:401.
17. Foster N., Clark M.A., Jepson M.A., Hirst B.H. Vaccine 1998, 16:536.
18. Jain S., Singh P., Mishra V., Vyas S.P. Immunol. Lett. 2005, 101:41.
19. Mishra V., Mahor S., Rawat A., Dubey P., Gupta P.N., Singh P., Vyas S.P. Vaccine 2006, 24:5559.
20. Khatri K., Goyal A.K., Gupta P.N., Mishra N., Mehta A., Vyas S.P. Vaccine 2008, 26:2225.
21. Childers N.K., Michalek S.M. Novel Delivery Systems for Oral Vaccines 1994, 241. CRC Press, Boca Raton, FL. D.T. O'Hagan (Ed.).
22. Childers N.K., Denys F.R., McGee N.F., Michalek S.M. Regional Immunol. 1990, 3:8.
23. Chen H., Torchilin V., Langer R. J. Contr. Releases 1996, 42:263.
24. Chen H., Torchilin V., Langer R. Pharm. Res. 1996, 13:1378.
25. Kirby C., Gregoriadis G. Biotechnology 1984, 2:979.
26. Bogdanov A.A., Klibanov A.L., Torchilin V. FEBS Lett. 1998, 231:381.
27. Wang C., Smith R.L. Anal. Biochem. 1974, 63:414.
28. Vyas S.P., Sihorkar V., Dubey P.K. Pharmazie 2001, 56:554.
29. Snyder S.L., Sobocinski P.Z. Anal. Biochem. 1975, 64:284.
30. Zhang N., Oing Q.N., Huang G.H., Xu W.F. Int. J. Pharm. 2005, 294:247.
31. Ezpeleta I., Irache J.M., Stainmesse S., Chabenat C., Gueguen J., Orecchioni A.M. Int. J. Pharm. 1996, 142:227.
32. Clark M.A., Jepson M.A., Simmons N.L., Booth T.A., Hirst B.H. J. Histochem. Cytochem. 1993, 41:1679.
33. Elson C.O., Ealding W., Lefkowitz J. J. Immunol. Methods 1984, 67:101.
34. Nakane A., Numata A., Minagawa T. Infect. Immunol. 1992, 60:523.
35. Olde-Damink L.H.H., Dijkstra P.J., van Luyn M.J.A., van Wachem P.B., Nieuwenhuis P., Feijen J. Biomaterials 1996, 17:679.
36. Agrawal B.B., Goldstein I.J. Biochim. Biophys. Acta 1967, 133:376.
37. Isaka M., Yasuda Y., Mizokami M., Kozuka S., Taniguchi T., Matano K., Maeyama J., Mizuno K., Morokuma K., Ohkuma K., Goto N., Tochikubo K. Vaccine 2001, 19:1460.
38. Honda S., Suzuki S. Anal. Biochem. 1984, 142:167.
39. Neuta M.R., Mantis N.J., Frey A., Giannasca P.J. Semin. Immunol. 1998, 11:171.
40. Marcotte H., Lavoie M.C. Microbiol. Mol. Biol. Rev. 1998, 62:71.
41. Kunkel E.J., Butcher E.C. Nat. Rev. Immunol. 2003, 3:822.
42. Chionh Y.T., Wee J.L.K., Every A.L., Ng G.Z., Sutton P. P. Infect. Immun. 2009, 77:2962.
43. Senturk H., Tabak F., Akdogan M., Erdem L., Mert A., Ozaras R., Sander E., Ozbay G., Badur S. J. Gastroenterol. Hepatol. 2002, 17:72.
44. Roth-Watler F., Scholl I., Untersmayr E., Ellinger A., Boltz-Nitulescu G., Scheiner O., Gabor F., Jensen-Jarolim E. Vaccine 2005, 23:2703.
45. Zhou F., Kraehenbuhl J.P., Neutra M.R. Vaccine 1995, 13:637.
46. Harokopakis E., Hajishengallis G., Michalek S.M. Infect. Immun. 1998, 66:4299.